Page 147 - GPD-4-2

Gene & Protein in Disease BCL11A targets and chromatin binding patterns

E2-2 is an essential and specific regulator of plasmacytoid (Basel). 2022;14(14):3375.
dendritic cell development. Cell. 2008;135(1):37-48.
doi: 10.3390/cancers14143375
doi: 10.1016/j.cell.2008.09.016
33. Axelrod H, Pienta KJ. Axl as a mediator of cellular growth
28. Karrich JJ, Balzarolo M, Schmidlin H, et al. The transcription and survival. Oncotarget. 2014;5(19):8818-8852.
factor Spi-B regulates human plasmacytoid dendritic cell
survival through direct induction of the antiapoptotic gene doi: 10.18632/oncotarget.2422
BCL2-A1. Blood. 2012;119(22):5191-5200. 34. Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B. Continuous
doi: 10.1182/blood-2011-07-370239 expression of the transcription factor e2-2 maintains the
cell fate of mature plasmacytoid dendritic cells. Immunity.
29. Ceribelli M, Hou ZE, Kelly PN, et al. A druggable TCF4- and 2010;33(6):905-916.
BRD4-dependent transcriptional network sustains
malignancy in blastic plasmacytoid dendritic cell neoplasm. doi: 10.1016/j.immuni.2010.11.023
Cancer Cell. 2016;30(5):764-778. 35. García-Aznar JM, Alvarez SA, Del Castillo TB. Pivotal role of
doi: 10.1016/j.ccell.2016.10.002 BCL11B in the immune, hematopoietic and nervous systems:
A review of the BCL11A-associated phenotypes from the
30. Kamikubo Y. Genetic compensation of RUNX genetic perspective. Genes Immun. 2024;25:232-241.
family transcription factors in leukemia. Cancer Sci.
2018;109(8):2358-2363. doi: 10.1038/s41435-024-00263-w
doi: 10.1111/cas.13664 36. Engelsen AST, Lotsberg ML, Abou Khouzam R, et al.
Dissecting the role of AXL in cancer immune escape and
31. Caulier AL, Sankaran VG. Molecular and cellular resistance to immune checkpoint inhibition. Front Immunol.
mechanisms that regulate human erythropoiesis. Blood. 2022;13:869676.
2022;139(16):2450-2459.
doi: 10.3389/fimmu.2022.869676
doi: 10.1182/blood.2021011044
37. Schmid ET, Pang IK, Carrera Silva EA, et al. AXL receptor
32. Wang W, Xu J, Khoury JD, et al. Immunophenotypic
and molecular features of acute myeloid leukemia with tyrosine kinase is required for T cell priming and antiviral
plasmacytoid dendritic cell differentiation are distinct immunity. Elife. 2016;5:e12414.
from blastic plasmacytoid dendritic cell neoplasm. Cancers doi: 10.7554/eLife.12414

Volume 4 Issue 2 (2025) 7 doi: 10.36922/gpd.8131